Stocks

P&G Scoops Up Thorne for $3.8 Billion in Health Sector Play

Guavy AI Editorial Team Published August 5, 2026

Instruments

PG

Procter & Gamble Co. has acquired Thorne, a supplement maker, in an all-cash deal valued at $3.8 billion. The acquisition is part of P&G's health push, which was reported earlier this year. L Catterton took Thorne private in 2023.

The transaction is expected to be completed by the end of 2026's fourth quarter. This marks another significant investment for P&G as it expands its presence in the health and wellness industry.

Dow Rises Amid Mixed Market Sentiment, Private Payrolls Disappoint

Stocks 1m ago

Top Golfers Confirmed for Amgen Irish Open at Doonbeg

Stocks 1m ago

Disney's 'Toy Story 5' Boosts Earnings, Theme Park Attendance

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy